Saturday, October 26, 2024
■ The Week in Review
The new report was released as allies of Republican nominee Donald Trump push to make privatized Medicare Advantage plans the default enrollment option for U.S. seniors.
By Jake Johnson • Oct 24, 2024
"We believe that if Stellantis can afford to spend over $8 billion this year on stock buybacks and dividends, it can live up to the contractual commitments it made to the UAW."
By Brett Wilkins • Oct 24, 2024
"In these dangerous times, staying silent isn't just indifference, it is complicity," Mariel Garza wrote. "I'm standing up by stepping down from the editorial board."
By Jake Johnson • Oct 24, 2024
"I do not know any economist who thinks Trump would be a good president, or who thinks he would be good for the economy," said one of the signatories.
By Julia Conley • Oct 23, 2024
"There's nothing to be gained for everyday Americans by doubling down on the Trump corporate tax breaks—a historic mistake that added trillions to the deficit while threatening critical priorities like Social Security and Medicare."
By Jake Johnson • Oct 23, 2024
"This is what the Supreme Court has created by overthrowing the Constitution and the Declaration of Independence," said one progressive critic of the GOP nominee's remarks.
By Julia Conley • Oct 22, 2024
"Strong antitrust enforcement is not just good policy; it's also good politics," said the president of the American Antitrust Institute.
By Jake Johnson • Oct 22, 2024
"As eccentric and provocative as Elon Musk wants people to think he is, he's really just another corporate billionaire who wants to avoid accountability."
By Julia Conley • Oct 22, 2024
"With the new formulations of Roundup, Bayer had the opportunity to make us safer, but it did the opposite," one expert said.
By Olivia Rosane • Oct 22, 2024
"The State Department and the Department of Justice must investigate these credible charges of widespread and systematic human rights abuses," the head of one Muslim American advocacy group said.
By Brett Wilkins • Oct 21, 2024
